One more thing on pharmaceutical compounding rules that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent contradiction disappears.
28 likes 17mo
Topic summary
Pharmaceutical compounding rules, summarised from primary sources
This is a generated summary. It shows the 9 most-liked posts from a topic of 164, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
Post #24 put the caveat in the right place and I want to underline it.
Import rules for personal quantities differ from commercial import rules and both differ by country. Establishing your own position is not something a forum can do for you.
The right answer here may simply be that it has not been measured.
30 likes 17mo
The most useful thing anyone has posted about pharmaceutical compounding rules in this category was a table of what had been measured and by whom. That is what I would want again.
31 likes 17mo
Confirming post #37 from a second method, which matters more than confirming it from a second person.
Pharmaceutical compounding rules sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
32 likes 17mo
fr.translation_mo, post #39: Confirming post #37 from a second method, which matters more than confirming it from a second person. Pharmaceutical compounding rules sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly. Go to post
Taking post #96 at face value and following it one step further.
An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence.
I have seen it go both ways, which is why I hedge.
Second this, and I would have said it less carefully.
29 likes 17mo
Read the full topic (164 posts)
This topic was closed 90 days after the last reply. Closing is automatic for quiet topics so that a settled answer does not collect new questions underneath it. If you have a follow-up, open a new topic and link back to this one — that keeps both readable and gives your question its own title.
Moved from Vendor reports by t.vasquez. Category placement is not obvious from outside and getting it wrong is expected. This topic will get better answers here. The move is recorded in the public log citing R7.
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Research-use-only labelling: what it means and what it does not — the long version
Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not — the long version Everything below is what sits behind that. A labelling question, and I would like…
|
+150 | 158 | 55k | 14mo |
|
Pharmaceutical compounding rules, summarised from primary sources — a second dataset
Posting this under the heading it deserves: Pharmaceutical compounding rules, summarised from primary sources — a second dataset Everything below is what sits behind that. Asking what a regulator's document…
|
+50 | 56 | 780 | 8mo |
|
Coming back to: Research-use-only labelling: what it means and what it does not
Research-use-only labelling: what it means and what it does not — setting out what I have, and where I think it stops being reliable. A labelling question, and I would like the answer to be about what the…
|
+45 | 50 | 39k | 20mo |
|
Follow-up: How compounding permissions changed when supply normalised
How compounding permissions changed when supply normalised I have a specific reason for asking rather than idle curiosity, and the context is below. I was wrong about compounding permissions in a thread last…
|
+72 | 77 | 1.5k | 1d |
|
Import rules for personal quantities, by jurisdiction, dated
On the subject in the title: Import rules for personal quantities, by jurisdiction, dated Working notes rather than a conclusion. I was wrong about import rules for personal quantities in a thread last spring…
|
3 | 60k | 12mo |
Related topics — sharing the tags MHRA, EMA, research use only
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
About the Regulatory category
Research-use-only status, compounding rules, import restrictions, and the primary documents behind them. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
|
4 | 49k | 4mo | |
|
Labelling requirements for research chemicals
Labelling requirements for research chemicals — setting out what I have, and where I think it stops being reliable. The question about labelling requirements for research chemicals that I actually want…
|
+5 | 9 | 45k | 4mo |
|
Compounds this community declines to help with, and why
Compounds this community declines to help with, and why — setting out what I have, and where I think it stops being reliable. Putting the numbers in the first post, because a question about a compound without…
|
+81 | 87 | 35k | 10mo |
|
UK access routes, dated and sourced
UK access routes, dated and sourced Writing it up because I had to work it out twice and would rather nobody else did. Regional question, dated June 2026, because everything in this category expires. The…
|
2 | 5.8k | 15mo | |
|
Prescription portability between countries — the long version
On the subject in the title: Prescription portability between countries — the long version Working notes rather than a conclusion. A narrow question about Prescription portability between countries,…
|
2 | 182 | 21h |